You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brodalumab

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hidradenitis Suppurativa, Acne Inversa Trial in New York (Brodalumab)

Completed
  • Hidradenitis Suppurativa
  • Acne Inversa
  • Brodalumab
  • New York, New York
    The Rockefeller University
Jul 26, 2022

Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

Recruiting
  • Psoriasis Vulgaris
  • Venapuncture
  • Patient questionnaires
  • Ghent, Oost-Vlaanderen, Belgium
  • +6 more
Jan 16, 2023

Psoriasis Vulgaris Trial in Valencia (Brodalumab)

Recruiting
  • Psoriasis Vulgaris
  • Brodalumab
  • Brussels, Belgium
  • +21 more
Dec 12, 2022

Brodalumab in Psoriasis Inadequate Response to Their Current

Completed
  • Psoriasis
  • Brodalumab
  • Nanaimo, British Columbia, Canada
  • +10 more
Jul 13, 2022

Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)

Recruiting
  • Psoriasis
  • Brodalumab
  • +2 more
  • Brussels, Bruxelles-Capitale, Belgium
  • +21 more
Jan 27, 2023

Psoriasis Trial in United States (Brodalumab)

Recruiting
  • Psoriasis
  • Brodalumab
  • San Diego, California
  • +4 more
Sep 29, 2021

Psoriasis Trial in Bridgewater (Brodalumab, Comparator Drug (non-biologic IL-17 inhibitors))

Enrolling by invitation
  • Psoriasis
  • Brodalumab
  • Comparator Drug (non-biologic IL-17 inhibitors)
  • Bridgewater, New Jersey
    Registry
Dec 14, 2021

Rheumatoid Arthritis Trial (Brodalumab, Placebo, Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Brodalumab
  • +3 more
  • (no location specified)
Nov 22, 2021

Molecular Signatures in Inflammatory Skin Disease

Recruiting
  • Atopic Dermatitis
  • Psoriasis
  • Kiel, Germany
    Department of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022

Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis Trial in Worldwide (Brodalumab, Placebo, Guselkumab)

Completed
  • Plaque Psoriasis
  • +2 more
  • Brodalumab
  • +2 more
  • Wien, Austria
  • +52 more
Jan 11, 2023

Rheumatoid Arthritis Trial (Brodalumab, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Brodalumab
  • Placebo
  • (no location specified)
Oct 29, 2021

Psoriasis Trial in New York, Houston (Brodalumab)

Completed
Has Results
  • Psoriasis
  • Brodalumab
  • New York, New York
  • +1 more
Feb 16, 2021

Brodalumab in Plaque Psoriasis to Understand Impact on Quality

Recruiting
  • Psoriasis
  • Brodalumab
  • Matched cohort
  • Calgary, Alberta, Canada
  • +33 more
Oct 8, 2022

Moderate to Severe Plaque Psoriasis Trial in China (KHK4827-Active, KHK4827-Placebo)

Withdrawn
  • Moderate to Severe Plaque Psoriasis
  • Changchun, China
  • +24 more
Sep 24, 2021

Palmoplantar Psoriasis Trial (Brodalumab)

Unknown status
  • Palmoplantar Psoriasis
  • Brodalumab
  • (no location specified)
Nov 12, 2020

Psoriasis Trial (Fecal sample collection)

Unknown status
  • Psoriasis
  • Fecal sample collection
  • (no location specified)
Dec 17, 2020

Crohn's Disease Trial in Worldwide (Brodalumab)

Terminated
Has Results
  • Crohn's Disease
  • Brodalumab
  • Birmingham, Alabama
  • +33 more
Nov 30, 2021

Crohn's Disease Trial in Worldwide (Brodalumab, Placebo)

Terminated
Has Results
  • Crohn's Disease
  • Brodalumab
  • Placebo
  • Birmingham, Alabama
  • +50 more
Dec 1, 2021

Psoriasis, Psoriasis Vulgaris Trial in Gent, Nijmegen (Secukinumab, Ixekizumab, Brodalumab)

Recruiting
  • Psoriasis
  • Psoriasis Vulgaris
  • Brussels, Belgium
  • +18 more
Dec 5, 2022

Hidradenitis Suppurativa Trial in New York (Brodalumab)

Withdrawn
  • Hidradenitis Suppurativa
  • Brodalumab
  • New York, New York
    Rockefeller University Hospital
Sep 2, 2020

Hidradenitis Suppurativa Trial in New York (Brodalumab)

Completed
  • Hidradenitis Suppurativa
  • Brodalumab
  • New York, New York
    Rockefeller Unviersity
Jun 3, 2020

Asthma Trial in Worldwide (Placebo, Brodalumab)

Terminated
Has Results
  • Asthma
  • Placebo
  • Brodalumab
  • Birmingham, Alabama
  • +160 more
Feb 3, 2022

Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Tokyo (Brodalumab 210mg SC)

Completed
  • Psoriasis Vulgaris
  • +3 more
  • Brodalumab 210mg SC
  • Tokyo, Japan
    The Jikei University Scoole of Medicine
Dec 5, 2019

Psoriatic Arthritis Trial in Worldwide (210 mg brodalumab, 140 mg brodalumab, Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • 210 mg brodalumab
  • +2 more
  • Peoria, Arizona
  • +102 more
Aug 8, 2020

Psoriasis Trial in Aarhus (Brodalumab, Placebos)

Unknown status
  • Psoriasis
  • Brodalumab
  • Placebos
  • Aarhus, Denmark
    Aarhus University Hospital
Jul 9, 2019